Nuveen Asset Management LLC Has $27.20 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Nuveen Asset Management LLC reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,172,338 shares of the company's stock after selling 123,117 shares during the period. Nuveen Asset Management LLC owned approximately 0.69% of Option Care Health worth $27,198,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Cornerstone Investment Partners LLC increased its holdings in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares in the last quarter. UMB Bank n.a. increased its holdings in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Assetmark Inc. increased its holdings in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after purchasing an additional 487 shares in the last quarter. Pacer Advisors Inc. increased its holdings in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after purchasing an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management increased its holdings in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock valued at $553,000 after purchasing an additional 550 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.02 during midday trading on Wednesday, hitting $32.10. 68,203 shares of the stock were exchanged, compared to its average volume of 1,851,801. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a market capitalization of $5.26 billion, a price-to-earnings ratio of 26.97, a P/E/G ratio of 2.30 and a beta of 0.76. The business has a 50-day moving average price of $32.89 and a two-hundred day moving average price of $29.47. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.26 earnings per share. Sell-side analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.